4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:DNA表达载体
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Specialty_ELISA_kits > Oxford Genetics/pSF-CMV-FLuc-CMV-Cas9WT-BgH_Asc1 (OG3523) CRISPR/Cas9 Expression Plasmid/OG3523/1 Ea
商品详细Oxford Genetics/pSF-CMV-FLuc-CMV-Cas9WT-BgH_Asc1 (OG3523) CRISPR/Cas9 Expression Plasmid/OG3523/1 Ea
Oxford Genetics/pSF-CMV-FLuc-CMV-Cas9WT-BgH_Asc1 (OG3523) CRISPR/Cas9 Expression Plasmid/OG3523/1 Ea
Oxford Genetics/pSF-CMV-FLuc-CMV-Cas9WT-BgH_Asc1 (OG3523) CRISPR/Cas9 Expression Plasmid/OG3523/1 Ea
商品编号: OG3523
品牌: oxgene
市场价: ¥7047.40
美元价: 4228.44
产地: 美国(厂家直采)
公司:
产品分类: 特色ELISA试剂盒
公司分类: Specialty_ELISA_kits
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Plasmid Info:

Plasmid Information

Product Name: pSF-CMV-FLuc-CMV-Cas9WT-BgH_Asc1

Product Code: OG3523

Size (bp): 10913 bp

Bacterial Antibiotic Selection: AmpR

Origin and Compatibility: pUC high copy derived from pBR322

Bacterial Copy Number: 500-700 per cell

Promoter: Cytomegalovirus (CMV) immediate early promoter / Cytomegalovirus (CMV) immediate early promoter

Plasmid Purpose:

This dual expression vector is designed to express Cas9 from the CMV promoter in the Asc1 site as well as the firefly luciferase reporter gene from a CMV promoter in the main MCS.

Promoter Expression Level:

This plasmid contains the mammalian CMV promoter to drive gene expression. We have tested all of our mammalian promoters in a range of cell types and CMV is consistently the strongest in those we have studied. However there are many reports of the CMV promoter demonstrating silencing by methylation in long-term culture. For this reason we stock a range of other promoters that are compatible with this plasmid and are available on request.

Sequence and Map:

Other Info:

Transcription Termination:

This plasmid contains three alternative transcription terminators for mammalian bacterial and bacteriophage (T7) expression. This means that only the promoter needs to be changed to alter the expression system you are using. We sell multiple promoters that can be used in each of these systems. The presence of each terminator does not reduce expression in the alternative systems. The Cas9 protein is terminated by the Bovine growth hormone polyA signal.

Cloning:

Cloning in a gene:

This plasmid contains a gene (FLuc)within the main multiple cloning site (NotI-ClaI). Any plasmid that we sell where the gene is this configuration will be located in the exact same position in relation to the start and stop codon of the gene in the plasmid. The only exceptions to this rule are fusions proteins where the fusion gene may be positioned at the front or end of the MCS to allow gene fusion.

By positioning all of our genes in the same location it allows them to be transferred between plasmids using the same cloning method and restriction sites regardless of the plasmid being used from our product range. Inserting a new gene into this plasmid should be easily possible using a range of standard restriction enzyme sites that flank the gene currently in the vector.

Multiple cloning site notes:

There are a few important sites within the MCS. These include the NcoI site the XbaI site and the BsgI and BseRI sites. The NcoI site contains a start codon that is immediately downstream of both a Kozak and Shine-Dalgarno ribosomal binding site. These allow for optimal positioning of genes when the start codon is placed in this location. If this is not required and you wish to use a downstream site for gene cloning you can remove the NcoI site by cleaving the plasmid with KpnI.

BseRI and BsgI sites are non-palindromic and cleave a defined number of bases away from their binding sites. This allows them to cut the upstream stop codon in the gene in this plasmid regardless of the gene sequence.

IP Status:

Intellectual Property Status

This product is part of our SnapFast Pro plasmid range, for more information on the Intellectual property status of this plasmid please click here

品牌介绍
OXGENE的技术平台和专家解决方案加速了细胞和基因疗法的发现,开发和制造。我们解决了现代生物学中基因治疗,抗体治疗和基因编辑方面最重要和最具挑战性的问题。我们的技术可以实现精确而强大的哺乳动物细胞工程。我们以自动化和信息学为导向的方法意味着我们解决了其他人无法推进新疗法交付的问题。